lizzy241
33 seconds ago
JRoon, see below.
Yes, Amarin Pharma is currently considered a small cap company. As of February 2025, Amarin's market cap is approximately $222.53 million.
Since Amarin qualifies as a smaller reporting company, it has 90 days from the end of its fiscal year to file its